Edurant - Drug Details
๐Ÿ“Š Estimates Edurant Dialyzability By Different_Modalities

Edurant

Complete Drug Information

Drug Name
Edurant
Trade Names
Edurant, Rekambys
Pregnancy Category
AU: B1
Routes of Administration
Oral, intramuscular
Protein Binding
99.70%%
Metabolism
CYP3A4
Elimination
tablets: 45 hoursinjection: 13โ€“28 weeks
Excretion
85% via faeces, 6% via urine
Formula
C22H18N6
Molar Mass
366.428
Volume of Distribution
C22H18N6

๐Ÿคฐ Pregnancy Category Information

Category: AU: B1

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have not shown evidence of an increased occurrence of fetal damage.